Approval · Notice of Compliance 26050 · 2021
ADCETRIS: Notice of Compliance 26050
Issued June 11, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26050
- Date
- June 11, 2021
- Company
- Seagen Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADCETRIS | 02401347 | Marketed |
| ADCETRIS | Not yet assigned | — |
Medicinal ingredients
- BRENTUXIMAB VEDOTIN 50 MG per VIAL